buformin has been researched along with paclitaxel in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Li, J; Liu, Q; Tang, M; Wang, Y; Yu, J | 1 |
1 other study(ies) available for buformin and paclitaxel
| Article | Year |
|---|---|
Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Buformin; Cell Proliferation; Female; Humans; Hypoglycemic Agents; Neoplasm Invasiveness; Paclitaxel; Uterine Cervical Neoplasms | 2018 |